Fennec Pharmaceuticals Inc.

“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office

Who: Fennec Pharmaceuticals/Norgine B.V. What: Fennec licensed commercial rights to platinum chemotherapy-related hearing loss drug Pedmark in the EU, Australia and New Zealand to Norgine. Why: W

Omvoh (mirikizumab), Eli Lilly ’s treatment for moderately to severely active ulcerative colitis, is among the nine drugs that the European Medicines Agency this week said should be approved for use

Mirikizumab, Eli Lilly ’s investigational treatment for moderately to severely active ulcerative colitis, is among the nine products that the European Medicines Agency might this week decide whether